BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35304738)

  • 41. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
    Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
    Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutations of myelodysplastic syndromes (MDS): An update.
    Ganguly BB; Kadam NN
    Mutat Res Rev Mutat Res; 2016; 769():47-62. PubMed ID: 27543316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and molecular characteristics of acute myeloid leukemia with MPL mutation.
    Chen Y; Xie J; Shen Z; Shi J; Chen S; Wang G
    Hematology; 2022 Dec; 27(1):530-534. PubMed ID: 35544613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
    Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparison of chromosome karyotype between myelodysplastic syndrome and acute leukemia patients confirmed at the same period].
    Jiang M; Wen BZ; Li L; Chen S; Cheng H; Hao JP; Chen R; Wang L; Zhao F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):387-92. PubMed ID: 24763010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.
    Ren Y; Wang J; Zhang H; Mei C; Ye L; Luo Y; Zhou X; Zhu S; Jiang L; Wang L; Jin J; Tong H
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):172-179. PubMed ID: 32030889
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decitabine in the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes, Which Combined with Complex Karyotype Respectively.
    Gao S; Li Z; Fu JH; Hu XH; Xu Y; Jin ZM; Tang XW; Han Y; Chen SN; Sun AN; Wu DP; Qiu HY
    Asian Pac J Cancer Prev; 2015; 16(15):6627-32. PubMed ID: 26434886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotype.
    Kim SA; Hong J; Park WC; Shin DY; Koh Y; Kim I; Lee DS; Yoon SS
    PLoS One; 2018; 13(12):e0209800. PubMed ID: 30596716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype.
    Akagi T; Ogawa S; Dugas M; Kawamata N; Yamamoto G; Nannya Y; Sanada M; Miller CW; Yung A; Schnittger S; Haferlach T; Haferlach C; Koeffler HP
    Haematologica; 2009 Feb; 94(2):213-23. PubMed ID: 19144660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.
    Nardi V; Winkfield KM; Ok CY; Niemierko A; Kluk MJ; Attar EC; Garcia-Manero G; Wang SA; Hasserjian RP
    J Clin Oncol; 2012 Jul; 30(19):2340-7. PubMed ID: 22585703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis of RUNX1 Gene Mutation in Patients with Myelodysplastic Syndrome].
    Cai XH; Chen MY; Chao HY; Jiang NK; Lu XZ; Han WM; Qin W; Jia ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):202-208. PubMed ID: 32027277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The Genetic and Prognostic Characteristics of AML-MRC Patients].
    Chen Z; Mu QT; Wu A; Ouyang GF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):18-21. PubMed ID: 35123598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapy-related myeloid neoplasms.
    Ganser A; Heuser M
    Curr Opin Hematol; 2017 Mar; 24(2):152-158. PubMed ID: 27930389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia.
    Pemmaraju N; Shah D; Kantarjian H; Orlowski RZ; Nogueras González GM; Baladandayuthapani V; Jain N; Wagner V; Garcia-Manero G; Shah J; Ravandi F; Pierce S; Takahashi K; Daver N; Nazha A; Verstovsek S; Jabbour E; De Lima M; Champlin R; Cortes J; Qazilbash MH
    Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):110-4. PubMed ID: 25107338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamics of clonal evolution in myelodysplastic syndromes.
    Makishima H; Yoshizato T; Yoshida K; Sekeres MA; Radivoyevitch T; Suzuki H; Przychodzen B; Nagata Y; Meggendorfer M; Sanada M; Okuno Y; Hirsch C; Kuzmanovic T; Sato Y; Sato-Otsubo A; LaFramboise T; Hosono N; Shiraishi Y; Chiba K; Haferlach C; Kern W; Tanaka H; Shiozawa Y; Gómez-Seguí I; Husseinzadeh HD; Thota S; Guinta KM; Dienes B; Nakamaki T; Miyawaki S; Saunthararajah Y; Chiba S; Miyano S; Shih LY; Haferlach T; Ogawa S; Maciejewski JP
    Nat Genet; 2017 Feb; 49(2):204-212. PubMed ID: 27992414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes.
    Fabiani E; Fianchi L; Falconi G; Boncompagni R; Criscuolo M; Guidi F; La Brocca A; Hohaus S; Leone G; Voso MT
    Leuk Lymphoma; 2014 Jul; 55(7):1538-43. PubMed ID: 24047476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Genetics of Myelodysplastic Syndromes: Clinical Relevance.
    Chiereghin C; Travaglino E; Zampini M; Saba E; Saitta C; Riva E; Bersanelli M; Della Porta MG
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.
    Fernandez-Mercado M; Yip BH; Pellagatti A; Davies C; Larrayoz MJ; Kondo T; Pérez C; Killick S; McDonald EJ; Odero MD; Agirre X; Prósper F; Calasanz MJ; Wainscoat JS; Boultwood J
    PLoS One; 2012; 7(8):e42334. PubMed ID: 22912701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Analysis of ASXL1 gene variant in patients with myelodysplastic syndrome].
    Chen M; Liu J; Chao H; Qin W; Jiang N; Lu X; Cen L; Jiang Y; Cai X; Zhang R; Wang Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Feb; 37(2):110-115. PubMed ID: 32034733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.